Economic Evaluation of Axitinib for Second Line Treatment in Adult Patients with Advanced Renal Cell Carcinoma – the Portuguese Case
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2304
https://www.valueinhealthjournal.com/article/S1098-3015(14)04234-X/fulltext
Title :
Economic Evaluation of Axitinib for Second Line Treatment in Adult Patients with Advanced Renal Cell Carcinoma – the Portuguese Case
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04234-X&doi=10.1016/j.jval.2014.08.2304
First page :
A639
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1761